Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246554 · ClinicalTrials.gov registry record · Phase 3
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
A Phase 3 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 49
- Enrollment target
NCT04246554 is a Phase 3 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT04246554, a Phase 3 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 49 participants
- Enrollment target
Study Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.
Interventions
- DRUG Ketorolac
- DRUG Oxycodone-Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2021-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04246554
The ClinicalTrials.gov registry entry for NCT04246554 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT04246554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04246554 about?
NCT04246554 is a clinical study titled "Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery". 1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of...
What is the current status of trial NCT04246554?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 49 participants. The study started on 2019-05-21. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT04246554?
The interventions under investigation include: Ketorolac (DRUG), Oxycodone-Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT04246554?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.